Contract 80JSC022PA009

Cedars-Sinai Medical Center · National Aeronautics And Space Administration · July 16, 2024

Firm Fixed PriceSole SourceNAICS 541715

Cedars-Sinai Medical Center was awarded a federal contract by National Aeronautics And Space Administration on July 16, 2024 for $1.34 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in West Hollywood, CA. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 27, 2026. If all options are exercised, the contract could reach $3.53 million.

Obligated to date
$1.34M
$1,340,000
Current value
$3.53M
Modifications
5
Latest January 27, 2026

Contract details

PIID
80JSC022PA009
Award type
Purchase Order
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Not Competed Under Sap
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
Product / service
Space R&D Services; Space Flight, Research And Supporting Activities; Applied Research
Place of performance
West Hollywood, CA
First action
July 16, 2024
Latest action
January 27, 2026

Description

CEDARS-SINAI IS TO PERFORM ONE OR MORE PHASES OF THE INSPA PROGRAM TO DEVELOP, DEMONSTRATE AND MATURE SELECTED IN-SPACE MANUFACTURING OR PRODUCTION TECHNOLOGIES, LEADING TO SUCCESSFUL TRANSITION TO COMMERCIAL OPERATIONS ON A CLD.

Modification timeline

  • January 27, 2026
    Mod P00010 · Supplemental Agreement For Work Within Scope
    $2.93M
  • December 3, 2025
    Mod P00009 · Funding Only Action
    IN-SPACE PRODUCTION OF STEM CELL THERAPIES
    $2.03M
  • September 18, 2025
    Mod P00008 · Funding Only Action
    IN-SPACE PRODUCTION OF STEM CELL THERAPIES
    $1.88M
  • July 30, 2024
    Mod P00007 · Change Order
    IN-SPACE PRODUCTION OF STEM CELL THERAPIES
    $1.74M
  • July 30, 2024
    Mod P00006 · Funding Only Action
    IN-SPACE PRODUCTION OF STEM CELL THERAPIES
    $1.74M
  • July 16, 2024
    Mod P00005 · Supplemental Agreement For Work Within Scope
    IN-SPACE PRODUCTION OF STEM CELL THERAPIES
    $1.74M

Top contractors in NAICS 541715

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Fluor Marine Propulsion, Llc2$2.75B
2California Institute Of Technology240$979.40M
3The Johns Hopkins University Applied Physics Laboratory Llc204$482.74M
4Lockheed Martin Corporation4$461.91M
5Lockheed Martin Corp9$317.27M
6The Aerospace Corporation85$308.18M
7Fermi Forward Discovery Group, Llc1$289.92M
8Lockheed Martin Corp7$285.45M
9Amentum Technology, Inc.4$253.24M
10The Mitre Corporation50$222.51M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 80JSC022PA009?

Contract 80JSC022PA009 is a federal contract awarded to Cedars-Sinai Medical Center by National Aeronautics And Space Administration on July 16, 2024 for $1.34 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 5 times since the base award.

Who won contract 80JSC022PA009?

Cedars-Sinai Medical Center won contract 80JSC022PA009 from National Aeronautics And Space Administration.

How much is contract 80JSC022PA009 worth?

Contract 80JSC022PA009 has obligated $1.34 million to date, with a total potential value of $3.53 million if all options are exercised.